Follow TNGB
Pfizer Halts Obesity Drug Development After Patient Liver Injury Concerns
Pfizer has stopped developing its experimental weight-loss pill due to a patient suffering liver injury during…
Apr 14, 2025
Pfizer has stopped developing its experimental weight-loss pill due to a patient suffering liver injury during…
Eli Lilly has poured $550 million into building a massive pre-launch stockpile of its new oral…